About us

The company

 Revivocell is a UK spin-out from Lancaster University based at Sci-Tech Daresbury Science Incubator Hub, Warrington. We develop cell culture technology to improve life sciences research and enhance drug discovery success. We want to enable scientists to be more creative in their research by proving next dimension cell culture technology, which is easy to use and interactive, whilst closely mimicking body-like conditions and reduces animal testing.

Our technology

We have patent applications in novel cell culture devices that enable the growth of human cell culture in multi-dimensional forms in laboratory conditions, that better replicate the environment of living tissue.  Our new CELLBLOKS technology provides a unique customisable platform for multi-orgaphysiological experiments not provided by any other product. 

Current conventional "culture plates & peti-dishes" approaches are static and self-limiting.  Cells are grown in isolation that simply do not represent the real nature of human cell-cell interactions.  Whereas, current  organ-on-a-chip technologies are difficult to use, have limited throughput and require significant investment. 

Learn more

Our Team

Dr Valon Llabjani

Founder and CEO

He has a PhD in Biomedical Science and 15 years of life sciences research with commercial experience, successfully managing a number of academic and commercial projects. At Revivocell he  invented CELLBLOKS technology, has built a team that led to number patent applications and raised funding to support business development. He has experience in the inter-disciplinary fields of product design; 3-D cell culture, toxicology, polymer chemistry, cancer biology and analytical chemistry, and has published >20 academic peer reviewed journals.

Dr Valmira Hoti

Operations Director

Dr. Valmira Hoti is responsible for devising commercialisation strategies and operations. With a BSc (hons) in Banking & Finance, a PhD in Statistics (Lancaster) she also has worked in a bank's business growth sector assisting innovative start-ups with finance and commercialisation. 

Prof. Franics L Martin

Advisory Board 

Prof Martin’s group at University of Central Lancashire has an exemplary and world-leading record in the area of toxicology over many years. His laboratory specializes in the application of a range of toxicology tests, including the alkaline comet assay and the cytokinesis- block micronucleus assay. Prof Martin is current President of the UK Environmental Mutagen Society and Officer on the committee of its European counterpart, which has a significant industry component. He is also an Expert Member of the DoH Committee on Mutagenicity and on the OECD panel for developing a regulatory guideline for transformation assays.

Dr. Imran Patel

Advisory Board

Dr. Imran Patel has a PhD in Biological Sciences (Lancaster University), postdoctoral fellow training at the University of Cambridge, King Abdullah University of Science and Technology and an honorary postdoctoral fellow at Imperial College London NHS trust. He has extensive experience in application of vibrational spectroscopy for bio-sensing and bio-imaging of cancer, with particular emphasis on clinical translation.

Revivocell Limited

Daresbury Laboratory, Sci-Tech Daresbury, Keckwick Lane Daresbury, Cheshire, WA4 4AD

United Kingdom

Get directions